Table 3 The correlation between the activities of different uMMPs with clinico-pathological parameters
Clinic-pathological parameters | MMP-2 | MMP-9 | MMP-9/NGAL | MMP-9 dimer | MMP-9/TIMP | ADAMTS |
|---|---|---|---|---|---|---|
| Â | (%) | (%) | (%) | (%) | (%) | (%) |
Gender | Â | Â | Â | Â | Â | Â |
    Male | 56.3 | 65.6 | 62.5 | 54.2 | 16.7 | 25.0 |
    Female | 50.0 | 55.6 | 55.6 | 50.0 | 0.0 | 27.8 |
Age (year) | Â | Â | Â | Â | Â | Â |
    ≤ 60 | 47.8 | 52.2 | 56.5 | 47.8 | 34.8 | 21.7 |
    > 60 | 58.1 | 67.4 | 62.8 | 53.5 | 20.8 | 7.0 |
Tumor size | Â | Â | Â | Â | Â | Â |
    ≤ 5 cm | 52.8 | 58.3 | 58.3 | 52.8 | 16.7* | 13.9 |
    > 5 cm | 58.3 | 70.8 | 66.7 | 50.0 | 41.7 | 12.5 |
Tumor type | Â | Â | Â | Â | Â | Â |
    TCC | 55.6 | 62.2 | 60.0 | 53.3 | 13.3 | 22.2 |
    SCC | 52.4 | 61.9 | 61.9 | 52.4 | 9.5 | 33.3 |
Grade | Â | Â | Â | Â | Â | Â |
    1/2 | 48.8 | 58.1 | 53.3 | 48.8 | 16.3 | 27.9 |
    3/4 | 65.0 | 70.0 | 75.0 | 65.0 | 5.0 | 20.0 |
Bilharziasis | Â | Â | Â | Â | Â | Â |
    Present | 59.1 | 72.7 | 68.2 | 45.5 | 18.2 | 36.4 |
    Absent | 52.3 | 56.8 | 56.8 | 56.8 | 9.1 | 20.5 |
Lymph nodes | Â | Â | Â | Â | Â | Â |
    Present | 25.0 | 75.0 | 75.0 | 25.0 | 50.0 | 50.0 |
    Absent | 52.4 | 61.9 | 59.5 | 54.8 | 14.5 | 28.6 |
Prostatic invasion | Â | Â | Â | Â | Â | Â |
    Present | 60.0 | 80.0 | 80.0 | 60.0 | 20.0 | 30.0 |
    Absent | 42.9 | 50.0 | 50.0 | 50.0 | 14.3 | 21.4 |